Compare HOTH & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOTH | GVH |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 11.5M |
| IPO Year | 2018 | 2023 |
| Metric | HOTH | GVH |
|---|---|---|
| Price | $0.65 | $4.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 395.0K | 108.3K |
| Earning Date | 05-13-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $102,768.97 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $0.03 |
| 52 Week High | $2.12 | $10.74 |
| Indicator | HOTH | GVH |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 60.92 |
| Support Level | $0.49 | $4.02 |
| Resistance Level | $0.80 | $5.92 |
| Average True Range (ATR) | 0.04 | 0.89 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 11.82 | 52.02 |
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.